Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Repaglinide Monotherapy in New Onset Type 2 Diabetes
NCT02040246Phase 4Completed
- Sponsor
- Renji Hospital
- Start
- Feb 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of repaglinide in type 2 diabetes mellitus (T2DM), sponsored by Renji Hospital. Started Feb 2009; status: completed.
02
Drugs
repaglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02040246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040246.